Panel rules on second blood cancer drug case
(Credit: Shutterstock/PaeGAG)
An ICC tribunal has issued a partial award in a second arbitration between a Taiwanese pharmaceutical company and its Austrian partner over a blood cancer treatment – a case where the parties had been seeking US$5 billion.
To read more
Subscribe to Global Arbitration Review
Register for limited access
Register for free to receive GAR’s daily briefing and access to GAR 100.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now